BIOMAT Database Logo BIOMAT Database Logo

Use of living attenuated measles-virus vaccine in early infancy. 1960

J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK

UI MeSH Term Description Entries
D008457 Measles A highly contagious infectious disease caused by MORBILLIVIRUS, common among children but also seen in the nonimmune of any age, in which the virus enters the respiratory tract via droplet nuclei and multiplies in the epithelial cells, spreading throughout the MONONUCLEAR PHAGOCYTE SYSTEM. Rubeola
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles

Related Publications

J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK
[Living attenuated measles-virus vaccine. IV. Serological response of children before and after immunization with a living measles-virus vaccine].
January 1965, Nihon Ika Daigaku zasshi,
J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK
[Living attenuated measles-virus vaccine. VI. Results with a killed and living vaccine combination].
January 1965, Nihon Ika Daigaku zasshi,
J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK
[Living attenuated measles-virus vaccine. V. Protective affects and persistent immunity after inoculation with a living measles vaccine].
January 1965, Nihon Ika Daigaku zasshi,
J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK
INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
February 1965, Japanese journal of medical science & biology,
J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK
COMBINED USE OF HUMAN GAMMA-GLOBULIN AND LIVE MEASLES-VIRUS VACCINE WITH REFERENCE TO SINGLE INOCULATION OF LIVE MEASLES-VIRUS VACCINE IN EARLY INFANCY.
February 1965, Japanese journal of medical science & biology,
J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK
FURTHER STUDY OF THE USE OF LIVE ATTENUATED MEASLES-VIRUS VACCINE.
January 1964, Paediatrica Indonesiana,
J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK
Attenuated measles virus as a vaccine vector.
April 2007, Vaccine,
J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK
Inactivated measles virus vaccine. Subsequent challenge with attenuated live virus vaccine.
June 1963, JAMA,
J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK
Further-attenuated measles vaccine: characteristics and use.
January 1983, Reviews of infectious diseases,
J STOKES, and C M REILLY, and M R HILLEMAN, and E B BUYNAK
Use of live, attenuated measles virus vaccine in children allergic to egg protein.
September 1965, JAMA,
Copied contents to your clipboard!